| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Entrada Therapeutics, Inc. (TRDA) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. TRDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.96M | $21.01M | - | |
| 10% | 2.96M | $21.01M | - | |
| CEO | 526.0K | $3.73M | - | |
| 10% | 381.3K | $2.70M | - | |
| Pres | 216.3K | $1.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Dowden Nathan J70 | President &COO | Sell | 1,826 | $12.32 | $22,498.69 | -1.3% | +23.5% | -15.9% | |
| Feb 15, 2024 | Doshi Dipal62 | CEO | Sell | 1,000 | $15.00 | $15,000.00 | -0.4% | -3.5% | -10.5% | |
| Jan 16, 2024 | Doshi Dipal62 | CEO | Sell | 1,000 | $15.99 | $15,990.00 | -0.4% | -13.7% | -18.0% | |
| Dec 26, 2023 | Wentworth Kory James61 | Chief Financial Officer | Sale+OE | 12,500 | $15.59 | $194,845.26 | -5.8% | -19.8% | +6.3% | |
| Dec 20, 2023 | Doshi Dipal62 | President And CEO | Sell | 1,000 | $15.00 | $15,000.00 | -0.4% | -15.3% | +15.3% | |
| Nov 13, 2023 | Doshi Dipal62 | President And CEO | Sell | 1,000 | $16.23 | $16,230.00 | -0.4% | -7.4% | +20.7% | |
| Oct 17, 2023 | Doshi Dipal62 | President And CEO | Sell | 1,000 | $15.00 | $15,000.00 | -0.4% | -3.8% | +13.8% | |
| Sep 13, 2023 | Doshi Dipal62 | President And CEO | Sell | 1,000 | $15.00 | $15,000.00 | -0.4% | -8.4% | +3.4% | |
| Sep 6, 2023 | Wentworth Kory James61 | Chief Financial Officer | Sell | 950 | $13.48 | $12,806.17 | -0.9% | +1.2% | +10.9% | |
| Sep 6, 2023 | Kreher Nerissa54 | Chief Medical Officer | Sell | 892 | $13.48 | $12,021.75 | -1.1% | +1.2% | +10.9% |